Cellectar Biosciences, Inc. (CLRB) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Cellectar Biosciences, Inc. (CLRB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $10.0M, listed on NASDAQ, employing roughly 11 people, carrying a beta of 0.43 to the broader market. Cellectar Biosciences, Inc. Led by James V. Caruso, public since 2005-11-10.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for CLRB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →